BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/8/2022 7:44:25 AM | Browse: 144 | Download: 331
 |
Received |
|
2022-08-01 09:51 |
|
Peer-Review Started |
|
2022-08-01 09:51 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-08-21 10:26 |
|
Revised |
|
2022-09-08 07:53 |
|
Second Decision |
|
2022-10-19 03:39 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-10-19 06:56 |
|
Articles in Press |
|
2022-10-19 06:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-10-25 06:57 |
|
Publish the Manuscript Online |
|
2022-11-08 07:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Observational Study |
| Article Title |
T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hao Wu, Hui-Cong Sun and Gui-Fang Ouyang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ningbo Science and Technology Program |
2019A6-10312 |
|
| Corresponding Author |
Gui-Fang Ouyang, MD, Chief Physician, Department of Hematology, Ningbo First Hospital, Ningbo Clinical Research Center for Hematologic Malignancies, No. 59 Liuting Street, Ningbo 315010, Zhejiang Province, China. oyguifangoy@163.com |
| Key Words |
T-cell immunoglobulin mucin molecule-3; Transforming growth factor β; Chemokine-12; Diffuse large B-cell lymphoma |
| Core Tip |
Diffuse large B-cell lymphoma (DLBCL) is a malignant tumor with a poor prognosis. T-cell immunoglobulin mucin molecule-3 (Tim-3), transforming growth factor β (TGF-β), and chemokine 12 (CXCL12) can affect the prognosis of solid tumors by participating in the tumor immune escape. Therefore, we analyzed the effects of Tim-3, TGF-β, and CXCL12 expression on DLBCL prognosis. The results suggest that Tim-3 positive, TGF-β positive, and CXCL12 positive are independent risk factors; therefore, they can be used to evaluate the efficacy and prognosis of DLBCL patients. |
| Publish Date |
2022-11-08 07:44 |
| Citation |
Wu H, Sun HC, Ouyang GF. T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma. World J Clin Cases 2022; 10(32): 11804-11811 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i32/11804.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i32.11804 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
